A new oral GLP-1 pill recently showed up to 12% weight loss in a 36-week study, with manufacturers touting fewer side effects than injectable versions
Our product catalog reflects our commitment to advancing research excellence
A Fast Response Highly Selective Probe for the Detection of Glutathione in Human Blood Plasma
Injectable Forms : Intravenous or intramuscular injections can provide direct and efficient delivery of glutathione into the bloodstream, ensuring maximum absorption and benefit
Key Leaders: Herriot Tabuteau, MD, CEO Number of Employees: 800+ Stage: Public Financial Snapshot: $6.65 billion market cap Notable Investors: The Vanguard Group, BlackRock, and Blackstone (financial partner) Key Products: Axsome Therapeutics markets Auvelity for depression and Sunosi for excessive daytime sleepiness
Nguyen T, Yang CS, Pickett CB (2004) The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress